Follow this preprint
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: A practical review and meta-analysis
Masoud Etemadifar, View ORCID ProfileHosein Nouri, Maristella Pitzalis, Maria Laura Idda, View ORCID ProfileMehri Salari, Mahshid Baratian, Sepide Mahdavi, Amir Parsa Abhari, View ORCID ProfileNahad Sedaghat
doi: https://doi.org/10.1101/2022.02.12.22270883
Now published in Journal of Neurology, Neurosurgery & Psychiatry doi: 10.1136/jnnp-2022-329123
Masoud Etemadifar
aIsfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan Multiple Sclerosis Center, Isfahan Multiple Sclerosis Society, Isfahan, Iran
Hosein Nouri
aIsfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan Multiple Sclerosis Center, Isfahan Multiple Sclerosis Society, Isfahan, Iran
bNetwork of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran
Maristella Pitzalis
cInstitute for Genetic and Biomedical Research (IRGB) of National Research Council (CNR), Cagliari, Italy
Maria Laura Idda
cInstitute for Genetic and Biomedical Research (IRGB) of National Research Council (CNR), Cagliari, Italy
Mehri Salari
dFunctional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mahshid Baratian
eClinical Research Development Center, Islamic Azad University of Najafabad, Isfahan, Iran
Sepide Mahdavi
eClinical Research Development Center, Islamic Azad University of Najafabad, Isfahan, Iran
Amir Parsa Abhari
aIsfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan Multiple Sclerosis Center, Isfahan Multiple Sclerosis Society, Isfahan, Iran
bNetwork of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran
Nahad Sedaghat
aIsfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan Multiple Sclerosis Center, Isfahan Multiple Sclerosis Society, Isfahan, Iran
bNetwork of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran

Posted February 13, 2022.
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: A practical review and meta-analysis
Masoud Etemadifar, Hosein Nouri, Maristella Pitzalis, Maria Laura Idda, Mehri Salari, Mahshid Baratian, Sepide Mahdavi, Amir Parsa Abhari, Nahad Sedaghat
medRxiv 2022.02.12.22270883; doi: https://doi.org/10.1101/2022.02.12.22270883
Now published in Journal of Neurology, Neurosurgery & Psychiatry doi: 10.1136/jnnp-2022-329123
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3234)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13250)
- Forensic Medicine (19)
- Gastroenterology (891)
- Genetic and Genomic Medicine (5066)
- Geriatric Medicine (471)
- Health Economics (773)
- Health Informatics (3189)
- Health Policy (1129)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4811)
- Nursing (254)
- Nutrition (716)
- Oncology (2483)
- Ophthalmology (703)
- Orthopedics (279)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (531)
- Pediatrics (1281)
- Primary Care Research (550)
- Public and Global Health (7372)
- Radiology and Imaging (1669)
- Respiratory Medicine (970)
- Rheumatology (473)
- Sports Medicine (416)
- Surgery (534)
- Toxicology (69)
- Transplantation (233)
- Urology (199)